seventh ovarian cancer day fall 8 forum ovarian cancer prevent treatment held tuesday beij health time health public affili peopl dailyindustri figur attend call increas effort develop domest produc drug promot standard treatment procedur provid diseas care ovarian cancer patient chinawu lingi director gynecolog oncolog depart cancer hospit chines academi medic scienc ovarian cancer difficult detect 70 percent ovarian cancer patient diagnos late stage major patient cancer relapsesa time window relaps shorten fiveyear surviv rate cancer low ad standard treatment procedur deliv outcom patientsliu wengui founder mijian 360com onlin communiti cancer patient famili lot drug treatment emerg cancer ovarian cancermani patient worri medicin shortag relaps saidliang yi chief commerci offic china presid zai lab biopharmaceut compani base shanghai compar cancer affect popul ovarian cancer receiv attent pharmaceut industri public chinah compani devot bring treatment chines patient fast china nation medic product administr earlier accept compani drug applic zejula niraparib zl2306 categori drug fasttrack reviewth drug mainten treatment adult patient recurr epitheli ovarian fallopian tube primari periton ovarian cancer complet partial respons platinumbas chemotherapysong ruilin execut presid china pharmaceut innov develop associ chines pharmaceut compani remark progress drug develop yearsh hope innov chines pharmaceut compani provid drug chines cancer patient cancer affect popul china countri